問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberGS-US-417-0304
NCT Number(ClinicalTrials.gov Identfier)
Completed

2018-08-01 - 2025-12-31

Phase III

Terminated10

ICD-10M06

Other rheumatoid arthritis

ICD-10M06.9

Rheumatoid arthritis, unspecified

ICD-9714.0

Rheumatoid arthritis

  • Trial Applicant

    Pharmaceutical Research Associates Taiwan Inc.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator KO-JEN LI Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Audit

None

Principal Investigator 吳詹永嬌 風濕免疫科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 陳宏安 風濕免疫科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 曾瑞成 Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 魏正宗 Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Chi-Ching Chang Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

1 Stop recruiting

Audit

None

Principal Investigator 陳相成 風濕免疫科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Yao-Fan Fang Division of Rheumatology
Linkou Chang Gung Medical Foundation

Taiwan National PI

方耀凡

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

3 Stop recruiting

Audit

None

Principal Investigator Joung-Liang Lan 風濕免疫科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    141 participants

  • Global

    2800 participants